Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T; Atomoxetine ADHD Study Group..

Pediatrics. 2001 Nov;108(5):E83.

PMID:
11694667
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
4.

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder.

Christman AK, Fermo JD, Markowitz JS.

Pharmacotherapy. 2004 Aug;24(8):1020-36. Review.

PMID:
15338851
5.

Atomoxetine.

Simpson D, Perry CM.

Paediatr Drugs. 2003;5(6):407-15; discussion 416-7. Review. Erratum in: Paediatr Drugs. 2003;5(10):661. Dosage error in article text.

PMID:
12765489
6.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

8.

Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder.

Corman SL, Fedutes BA, Culley CM.

Am J Health Syst Pharm. 2004 Nov 15;61(22):2391-9. Review.

PMID:
15581262
9.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
10.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
11.

Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder.

Vaughan B, Fegert J, Kratochvil CJ.

Expert Opin Pharmacother. 2009 Mar;10(4):669-76. doi: 10.1517/14656560902762873 . Review.

PMID:
19239401
12.
13.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
14.

Atomoxetine for treating ADHD symptoms in autism: a systematic review.

Ghanizadeh A.

J Atten Disord. 2013 Nov;17(8):635-40. doi: 10.1177/1087054712443154. Review.

PMID:
22544388
15.

The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical research.

Savill NC, Buitelaar JK, Anand E, Day KA, Treuer T, Upadhyaya HP, Coghill D.

CNS Drugs. 2015 Feb;29(2):131-51. doi: 10.1007/s40263-014-0224-9. Review.

PMID:
25698145
16.

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Dell'Agnello G, Zuddas A, Masi G, Curatolo P, Besana D, Rossi A.

CNS Drugs. 2009 Sep;23(9):739-53. doi: 10.2165/11314350-000000000-00000. Review.

PMID:
19689165
17.

Cardiovascular effects of atomoxetine in children, adolescents, and adults.

Wernicke JF, Faries D, Girod D, Brown J, Gao H, Kelsey D, Quintana H, Lipetz R, Michelson D, Heiligenstein J.

Drug Saf. 2003;26(10):729-40. Review.

PMID:
12862507
18.

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder.

Pliszka SR, Crismon ML, Hughes CW, Corners CK, Emslie GJ, Jensen PS, McCracken JT, Swanson JM, Lopez M; Texas Consensus Conference Panel on Pharmacotherapy of Childhood Attention Deficit Hyperactivity Disorder..

J Am Acad Child Adolesc Psychiatry. 2006 Jun;45(6):642-57.

PMID:
16721314
19.

Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review.

Wilens TE, Biederman J, Spencer TJ, Prince J.

J Clin Psychopharmacol. 1995 Aug;15(4):270-9. Review.

PMID:
7593710
20.

Guanfacine extended release in the treatment of attention deficit hyperactivity disorder in children and adolescents.

Connor DF, Rubin J.

Drugs Today (Barc). 2010 May;46(5):299-314. doi: 10.1358/dot.2010.46.5.1450095. Review.

PMID:
20517532
Items per page

Supplemental Content

Support Center